Behavior of SelectMDx and Prostate-specific Antigen Density in the Challenging Scenario of Prostate Imaging-Reporting and Data System Category 3 Lesions.

作者信息

Morote Juan, Díaz Fernando, Celma Anna, Planas Jacques, Trilla Enrique

机构信息

Department of Urology, Vall d'Hebron Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

Eur Urol. 2022 Jan;81(1):124-125. doi: 10.1016/j.eururo.2021.09.019. Epub 2021 Sep 30.

DOI:10.1016/j.eururo.2021.09.019

PMID:34602313

Abstract

摘要

相似文献

[1]

Behavior of SelectMDx and Prostate-specific Antigen Density in the Challenging Scenario of Prostate Imaging-Reporting and Data System Category 3 Lesions.

Eur Urol. 2022-1

[2]

Concordance and Performance of 4Kscore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.

Urology. 2020-7

[3]

Micro-ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI-RADS 3 lesions.

Cancer. 2023-1-15

[4]

Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5.

Int J Urol. 2019-2

[5]

Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.

World J Urol. 2017-2

[6]

PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.

J Urol. 2019-1

[7]

[MRI of the prostate].

Urologe A. 2017-5

[8]

Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.

J Urol. 2014-12

[9]

Outcomes of Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions.

Can Assoc Radiol J. 2018-8

[10]

Inflammation appears as high Prostate Imaging-Reporting and Data System scores on prostate magnetic resonance imaging (MRI) leading to false positive MRI fusion biopsy.

Investig Clin Urol. 2019-7-30

引用本文的文献

[1]

Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.

Prostate Cancer Prostatic Dis. 2025-3

[2]

A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer.

PLoS One. 2024

[3]

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand.

Cancers (Basel). 2022-10-18

[4]

Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.

Eur Urol Open Sci. 2022-1-23

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Behavior of SelectMDx and Prostate-specific Antigen Density in the Challenging Scenario of Prostate Imaging-Reporting and Data System Category 3 Lesions.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献